Obsessive-compulsive disorders due to neuroacanthocytosis treated with citalopram.
Walker
R H
RH
1Department of Neurology, James J. Peters Veterans Affairs Medical Center, Bronx, and Mount Sinai School of Medicine, New York, NY, USA.
Danek
A
A
D000328:Adult; D026921:Amino Acid Transport Systems, Neutral / Q000235:genetics; D002819:Chorea / Q000150:complications* / Q000188:drug therapy* / Q000235:genetics; D015283:Citalopram / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009771:Obsessive-Compulsive Disorder / Q000209:etiology* / Q000235:genetics; D010641:Phenotype; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*
D026921:Amino Acid Transport Systems, Neutral; D015283:Citalopram; D017367:Selective Serotonin Reuptake Inhibitors; C087883:XK protein, human